{"ticker": {"uuid": "87a62723-7ed3-4f58-bf60-d8284fd599db", "symbol": "DHR", "name": "Danaher Corporation", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS", "summary": "Danaher (DHR) is projected to report Q2 earnings of $1.84 per share and revenues of $6.09 billion, representing year-over-year increases of 2.2% and 2.6% respectively. Analysts have made slight downward adjustments to the EPS estimate, which can influence investor actions. Beyond", "url": "https://finance.yahoo.com/markets/stocks/articles/countdown-danaher-dhr-q2-earnings-131503448.html", "source_name": "Market source", "published_at": "2026-07-16T13:08:11", "published_display": "16 Jul 2026 13:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics", "summary": "Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform,", "url": "https://manufacturingchemist.com/leica-biosystems-acquires-statlab-to-strengthen-anatomic-pathology", "source_name": "Manufacturing Chemist", "published_at": "2026-07-16T11:26:45", "published_display": "16 Jul 2026 11:26", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (DHR) Price Events", "summary": "This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide trading strategies and multi-timeframe signal analysis. It indicates strong near and mid-term sentiment but a weak long-term outlook, highlighting a significant risk-reward short setup. The analysis ", "url": "https://news.stocktradersdaily.com/news_release/38/Liquidity_Mapping_Around_DHR_Price_Events_071626064402_1784198642.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-16T07:07:39", "published_display": "16 Jul 2026 07:07", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as diversified life sciences portfolio underpins long-term growth", "summary": "Danaher Corp. (ISIN US2358511028) is highlighted as a global life sciences and diagnostics supplier, appealing to long-term investors due to its diversified portfolio and recurring revenue streams. The company's focus on essential laboratory and clinical workflows, alongside stra", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-diversified-life-sciences-portfolio/69776007", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-16T00:42:00", "published_display": "16 Jul 2026 00:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher\u2019s Leica Biosystems to Acquire StatLab", "summary": "Danaher's Leica Biosystems is set to acquire StatLab, a privately-held manufacturer of anatomical pathology products. StatLab, with over 50 years of history, offers products for pre-analytical and analytical histology, complementing Leica Biosystems' focus on cancer diagnostics. ", "url": "https://www.mpo-mag.com/breaking-news/danahers-leica-biosystems-to-acquire-statlab/", "source_name": "Medical Product Outsourcing", "published_at": "2026-07-15T14:37:54", "published_display": "15 Jul 2026 14:37", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock may move 4.9% on July 21 earnings report By Investing.com", "summary": "Danaher Corp. (DHR) shares are expected to move 4.9% following its earnings report on July 21, based on options data. The stock has historically surpassed this options-implied movement in three of its last eight earnings announcements. Notably, on October 21, 2025, shares increas", "url": "https://za.investing.com/news/stock-market-news/danaher-stock-may-move-49-on-july-21-earnings-report-93CH-4368568", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T10:07:45", "published_display": "15 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Audax and Linden to sell StatLab Medical Products", "summary": "Audax Private Equity and Linden Capital Partners are reportedly selling StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation. The article, by Iris Dorbian, was published two hours prior to the provided crawl time. Further details about the dea", "url": "https://www.pehub.com/audax-and-linden-to-sell-statlab-medical-products/", "source_name": "PE Hub", "published_at": "2026-07-15T08:08:33", "published_display": "15 Jul 2026 08:08", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher's Leica Biosystems to Acquire StatLab Medical Products", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/danaher-apos-leica-biosystems-acquire-215836046.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:58:36+00:00", "published_display": "14 Jul 2026 21:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lab-products maker StatLab set to join Danaher\u2019s Leica", "summary": "Audax Private Equity and Linden Capital Partners have reached an agreement to sell StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation (NYSE: DHR). StatLab, a manufacturer of pre-analytical products for anatomic pathology, expanded globally a", "url": "https://www.stocktitan.net/news/DHR/audax-private-equity-and-linden-capital-partners-agree-to-sell-stat-cnl6do9mgva0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:24:38", "published_display": "14 Jul 2026 21:24", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Implied Volatility Surging for Danaher Stock Options", "summary": "Implied volatility for Danaher Corporation (DHR) stock options is surging, particularly for the Sept. 18, 2026 $140 Call, indicating that the market expects a significant price move. While analysts have slightly reduced current quarter earnings estimates, Danaher remains a Zacks ", "url": "https://www.tradingview.com/news/zacks:50863780b094b:0-implied-volatility-surging-for-danaher-stock-options/", "source_name": "TradingView", "published_at": "2026-07-14T20:07:38", "published_display": "14 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leica Biosystems to Acquire StatLab", "summary": "Leica Biosystems, a Danaher operating company and leader in precision cancer diagnostics, announced its definitive agreement to acquire StatLab Medical Products. StatLab, previously owned by Linden Capital Partners and Audax Private Equity, is a global developer and manufacturer ", "url": "https://finance.yahoo.com/healthcare/articles/leica-biosystems-acquire-statlab-203000239.html", "source_name": "Market source", "published_at": "2026-07-14T20:07:37", "published_display": "14 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 DANAHER CORP /DE/ For: 14 July", "summary": "This article reports on a Form 144 filing for Danaher Corporation on July 14. It primarily consists of boilerplate disclaimers about the risks of trading in financial instruments and cryptocurrencies, emphasizing that the provided data may not be real-time or accurate. The conten", "url": "https://m.uk.investing.com/news/stock-market-news/form-144-danaher-corp-de-for-14-july-93CH-4770216?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-14T15:38:15", "published_display": "14 Jul 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] DANAHER CORP /DE/ SEC Filing", "summary": "This SEC filing, Form 144, for Danaher Corporation (DHR) concerns the proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing indicates a neutral impact and sentiment. It details the sale of 3298 shares of common stock, acquired via stock option exerc", "url": "https://www.stocktitan.net/sec-filings/DHR/144-danaher-corp-de-sec-filing-0fdb16e95ddd.html", "source_name": "Stock Titan", "published_at": "2026-07-14T15:16:03", "published_display": "14 Jul 2026 15:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMDFpdDB6ZVkxVWhJblZWR05wLUt3cV9wb2xzWTVfb3JaUXdCeUYzbjBXeHBFcU9uSGczWTNlSU9Vd21ueGFtT3N3WTRSQzRTWjZSb1UxMDdPVmJMa01fV3hDUXNvSXl4eTlxZ0RaTExuc0FNd1V2UVJaWGtSV052N2tucHJDM2FvVkFZWlhTWl8zQVB3ZGl1Q2RR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:00:09+00:00", "published_display": "14 Jul 2026 14:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as diversified diagnostics and life sciences portfolio supports long term", "summary": "Danaher stock reflects the company's diversified portfolio across diagnostics, biotechnology tools, and environmental solutions, which helps stabilize its performance for investors. The company's strategy involves acquiring niche businesses and integrating them into its science a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-diversified-diagnostics-and-life-sciences/69763195", "source_name": "Ad Hoc News", "published_at": "2026-07-14T02:26:46", "published_display": "14 Jul 2026 02:26", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-adjusts-price-target-danaher-135410367.html", "source_name": "MT Newswires", "published_at": "2026-07-13T13:54:10+00:00", "published_display": "13 Jul 2026 13:54", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as investors await the next catalyst", "summary": "Danaher stock is holding steady, focusing on its diagnostics, life sciences, and biotech tools franchises as investors look for new catalysts. The company, a major U.S. life-sciences and diagnostics name, benefits from diversification across its business mix, which includes tools", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-investors-await-the-next-catalyst/69758786", "source_name": "Ad Hoc News", "published_at": "2026-07-13T07:28:00", "published_display": "13 Jul 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as its life sciences platform stays central", "summary": "Danaher Corporation (DHR) maintains its stable market position due to its diversified life sciences, diagnostics, and biotechnology platform. The company's business model, heavily reliant on recurring revenue from instruments, consumables, and services, offers resilience compared", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-its-life-sciences-platform-stays-central/69749752", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T05:57:00", "published_display": "12 Jul 2026 05:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as analysts frame the outlook", "summary": "Danaher Corporation's stock remains stable due to its extensive presence in the life sciences and diagnostics sectors, positioning it as a significant supplier across research, bioprocessing, and diagnostics markets. Its diversified business model, characterized by recurring dema", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-analysts-frame-the-outlook/69741204", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:44:00", "published_display": "11 Jul 2026 06:44", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Is Getting Better, But The Stock Still Isn't Cheap (NYSE:DHR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNbUJQd2dnaUNhWFplV2RQd190Wnp0NTZNRDJBTEoza0tHcG1jNFlUN2tvM0JRXzFCSU1JLXFra2UzMXM1dmJZbjFkY21WaVhUZ1NvWU1FRHhBLWQzc1NLTGYxcmk2TW5Pc0IweUZ4RER2OHZ0dXNna3hpNmN0Z09tWTRkWXBhTGJqQXBfQy1fOXgwS2lpR0tCbUxLUm15dw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T21:44:45+00:00", "published_display": "10 Jul 2026 21:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Labs Vs. Danaher: Abbott\u2019s Everyday Products Beat Danaher\u2019s Slumping Biotech Equipment", "summary": "The article compares Abbott Laboratories (ABT) and Danaher (DHR) after their Q1 2026 earnings, highlighting Abbott's reliance on consumer medical devices like FreeStyle Libre and Danaher's dependence on bioprocessing tools. Abbott's consumer-facing products demonstrate recession-", "url": "https://247wallst.com/investing/2026/07/10/abbott-labs-vs-danaher-abbotts-everyday-products-beat-danahers-slumping-biotech-equipment/", "source_name": "24/7 Wall St.", "published_at": "2026-07-10T18:18:58", "published_display": "10 Jul 2026 18:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. stock outperforms competitors on strong trading day", "summary": "Danaher Corp. (DHR) stock rose 1.57% to $199.05 on Friday, outperforming the broader market indexes. The S&P 500 Index increased by 0.42%, and the Dow Jones Industrial Average gained 0.29%. This marked the second consecutive day of gains for Danaher's stock.", "url": "https://www.marketwatch.com/data-news/danaher-corp-stock-outperforms-competitors-on-strong-trading-day-1e1b34e2-1c759d009ffc", "source_name": "MarketWatch", "published_at": "2026-07-10T16:36:00", "published_display": "10 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Wins CE Mark For Access P Tau217 Assay, Is The Stock A Bargain?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNN2c1S0JjdkIxdWtVU2lzNWtnQXIybnV1OFViNXhhd0p1XzNkQmNNaDlnbFlkNEIyMUFCY3RrUHlWSzBxTXhaTnlsX1ZrbVNaZm5GcjVwaUl3N09aRGZ4cDUtc0VTVGpKZU1fSkVmQWxNQ3V0YzBhUy1VRGFkTFc5ZFlSZXNibjhzdG1TMDNtVnRtR2c?oc=5", "source_name": "Market source", "published_at": "2026-07-09T21:15:54+00:00", "published_display": "09 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Gains Attention On FDA Clearance, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxON2xpbncyVjlNSG5ZZ3RUSXRIa0czcTI2NHVmam1VWlRNa1BOVEdNc3ViZllTT1ZaV1NYTm1QVk83SzZ3clctSVRsUUkxU1ljVDIwckhwZVhTREJxQUZySUZ4WUh6LU1hV3FnZUZkeTVlOGI4LXFuamN6N0hvc3pyMXVDVFE4SE84b2E2U2xLdEJHVHZkaGhwWUtTWWo1SzdwV3lzSTItb0JJT1JsZTBYbGJ2RmlzcHZNVV91TmVoajVnRlBZZjF1TkZwaGJlTHk5U0JuYtIB2gFBVV95cUxPbmQtTVQxUWM2eGN0YU1aazczb1NVOW1LX3NmZkF1X2JHTGlDTHVqdWloemtVRzBzTVBjU3JvYUV6ajRKUEhfZmtGb3hZYXJ0Ulk4UWlxQnlMc1ZHTTE1bjV5NGNUYlBuRkdBb0d1d0VSUzJla1FTcnBMUm01amtldzBKYXFZWTNQM2tvM3FyZFI3NWt2bWRPMW1sSlR3X1RUWV9QRzhrRGdLN3YtVC1vUGNoOFFpMjRjNXN6YVRBaDUtWDVzUnFJQmpJYVJSUDlTT3pkUGppM3hOZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. focuses on life sciences growth as investors watch long-term strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOanZxV29EV1AyMHRaaFUzdFdndmg4dENqVGlHaENzR25NZDZSTkE3bEVNS2pxQ0pyVVdMN3B4ZGNmUE9vcWMzX1NndlYwVlhra3R4SGY3TmZlakVmVGZIcUpDTVhLdXRxc1NLSGZFY1kyWU9ZdkMwdE9IQ1BramdGTVlRekRrbHE1UmxDbE5BWmZIV09fdFhwa25KeHNXZUtPSlBzbFBDUXRLRU83Q3lpVU1PenJia1VpRHg3QTF6dy0wdTA1Y1hldW9yTjg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Weighs DCF Upside Against Premium P/E After Recent Bounce", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T19:27:10+00:00", "published_display": "30 Jun 2026 19:27", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQWlExWHROd2ItQUNCRTlRd3piNnBKUEFaV0NGMU8zcF9QbXdWdzdXYkw4cTNjU0p2ODhra0VKZlI0aldrMjFBMjYzM0pyalI3LUFTbmk5QnNhek83R1pGLVhuLU9FR1BDX1NkQTBQVFhqZzZybXZVR3dYcEZLbV9uaTdWWjlFVHQ1Q1ZsRldnZno0Rkk?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (NYSE: DHR) Stock price Drops 22% In 2026 As $9.9 Billion Masimo Deal Reshapes The Investment Case", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZl9ieDZYUlJzWmRxd3FfdGtqZzJqbHNoZWNGY3FYZ192Qzh2Y1UwTTFxNDJNNTFLcW51dXBrcGZDS2wtZi1tV1JFVXB6MWxCWGo1VG5fQW9lbUtzUHQ2SlFJVlRwcGdCV1JDVzZ2QkpaMV84NlRSeGdrbzJyeVFYUUxMdk52OE9ZTWJJVWlGdl93UEhSNFFadjRtV3NYSklNT0xyN2twaEw4SW1aYjZpcWZJU3U4cWluM2ZVdTJaVWVuN2dfcGxsV1FEM0FPTzBtRjlUck1wMm5wYUUzYlpfRnE3eHg?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-25T13:32:00+00:00", "published_display": "25 Jun 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNW1IS19mZjk2Z1hIajlLbjhCWjJlV3JtX29CaE1IazV6S1lOVlNFUWhNNWNKZXYzTHVMdXJmMC10V3FrQzlEd2g2dkh6VF9tZkhlMmNCN0JQelZlZ1MwMkpTbFdqUHJudERGOG5VWjBjd2NGRzJjVF9jRDZCazMtSmJ5NHZCZ2V1ZzQtWExpbDM?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Danaher (DHR) Stock Rose Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBZV24yRXVIZVpwOF9CN3BuNXVUa2JVOU1tazQxRDAzUV83TXVPVkk5TzRVcUEzb3BzaFpobnA0elQ2cTd6R0M2alphV09lM2pRdVVjY3JZd2FWUm5pOGJKYzE0ZzdZZ2dNSTAySTJ5TGNqZjRiMTRUUUY1TQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOVXpJeHNKTlYzQTR6Wkg4dFdWbTRydFFKWlBfOE1YV0lOdnlqVF9LWll0Smw3S1NLbHRBTzNDOUJaSzhCQ2txVW9qRTY3OFZvRzh0V0tDU25BekNuMGJFS2h3Z1MxMWpHb3NocTJaUVlQS1NqUXZwN3pJNGs0d3diR2VYVVVCZnUzX0VIQ0tXXzQ5ZWtaUVMyV2hiWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher\u2019s (DHR) Clinical Data Advantage", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HSBC Cuts PT on Danaher Corporation (DHR) \u2013 Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNWXRQYWJ1NDgtNm0yV2YwcHJQLUFrTWo5U015aXBEeVRYSy1BWXl0RXdKbk85Uy1sQmdHcGlSRWcxNUFfRGFqbFpES3Zvdk9XUHhpQW1oSjE5V0UzcXZBbThrUXBrbzUtcEQzdkFBOUp6clBfczg5Uk1sUGlncWNYQzVXNS12S2gyNC16UmxoUUh5S1dYRjVzUjg0aWZkUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why You Might Be Interested In Danaher Corporation (NYSE:DHR) For Its Upcoming Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corporation\u2019s (DHR) Recovery Fell Short of Investor Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNaGt6RWlsOVQ3T2xGSGxYT3VpRkJVXzlneGgwRUxONWtTSmxkNnJteVZ3U29UYkFwMmVQclFraDE0VDRCc25oZFFhVlVZYjN6ekxad05OZUgtS29yNmR4N2pGeU82Z0FUVEZQZmpkb09DZHRUdWdiUVZJc2xyR1dtcDMyTDktNGw3SFdRZGNTUU1CRnZHMlFMTm5GTU92bHlGV2ZabA?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaEhzdTJLeWZnYkl2U2lmcFVTN0VldGxyLUZ3UEFTZkl2Z3ZZQkxfOXlqTmpfdFBJRHU0X0lhb2VpeEFYMG5TdmU3T1VNUHdBaEZ1bEVkSDYweW5uNXJiMndOd3NiUG9raXo3cHJrXzhoUGJnSWYtUmNJZGJYeGRfc0pRVlVFOXdDTld1MEN0UEVOVi12Q2wzODZ4a1pHRzFGcTZiMEFrLTdaUjBVOEJZTW9ZOGkxS0Z6OVhGaHNDUjYzelpT0gHKAUFVX3lxTE0xVkQ3QVBkeHBXLWRtVkktRW14ak05THV4aW13ZW9Yck5TUm1tNlFFaW02NGt2LXFjNE45OWd2dUdVd2xHR0UxRVBUclM0clFFNEtmMDZNVWpBYTN4UXpqVUkzUlo2blZTaUY1U3BhQ1MtSjNxRlRkQ1NVU0lld2xkMk9BSHd3VnZsbXVXZFIxY2pEamhSeXB6WFN4eG5mU3FXd2FtMkoyNkZNTTMxdU03ZHV6TVMwalRxcnI1Qmt2NDhZYzJfc1JLRXc?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Completes Acquisition of Masimo Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPWXdTanBwOEJMaXFoTU4xZl9FQ28yNk1YSVRsQVZYei1weW5ZUFNHQk9RTlQ2MUNWZVViR2FDVEwwQ29wTUh1VzljQVY3VW51aEx6bms0MEtoV1V0bEg1cS05SFFrQUtLc0tGMGxETEVHejBoczh0X2JFUGlvZTNkUXExdkRMVF9MdjFWSDZ4RE54NTJZdzR1RXN5WDc3Z2ZsSkRYS0t2ZlRVWXVrdzl4RC1RTQ?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQYUdlR2xKUHRlajdLeWVPMEFKbUxvalQ4NXZqU2lONDJZenM1UjV3TFFjWTQycTlkNHZ5cHVWWWlpQVc0YnVFMzNwTDdrclRiRWFIWlZSQWlubk5VTjZxZ0d3UHh5MkdYVThsSDVnZjdDWnVwMlpOQ0JfMko3Q0VqdEx2NVN3ZjNnVFZkMnQtTmp4cWRzRm14TTRkQUhjUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZk5FdWNPWnVUWWR0dnpWM0NUNUZkLXphcUZjYjdGX1daNDRqM3daQkdablpqSVZSMldqNExjYlhRQlBETlgwS1c5b0xLOUE2bDFkdm8wOTBrVnphc1FiWUlYNWpEMXg1cUZuY3ZHOHUwbDFjV2Zadl85Q3ZPd0lOQlFxekxQLTV2bExpVGNjY1FENXNwYS1xbzNIYTUyd2FaOXNyVEtQODQ5WWNEQk9mbTRXR24xT2ZOdWNJTWZnRFRrVmJ1Unc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock (US2358511028): Shares slide as institutional holdings shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNTjFMRGNHYXBGdEZQY3JRVTFHcUdDbUJMX01WVUthdmtfNjJ0UElFSW1pVlJjR1M4MHdTWExyR0dQSWZjRFJ5aERjRmRCb2VpQjJmaXlhS210TFozSEtNM2dDbFAzVlI3Nm5lWkdrVEtwdzJzd0RueTRuZ09FSEZQYThaLWFkeGNMelpYajJnWHAwQTdndHJwY2dBWjgwaW9hOTJGbzBVTUZZYVJSdDdJZEZyckd0NUQ3NzFqUTE2YkZ4T21MVWc4VFRR?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. Stock (US2358511028): Analyst Downgrades and 52-Week Low Test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPeTllekpBbXZaZzBLc21HQXBwOFRldGtBNDBmQkktTUxXcXJQWndCSnI0S2tQdzY3UkxfRDB5M0EyTWxTQjFSLWo0REU4QTMxMFNFZGp6bTlhcXFPQnRfbUhWTkNzT0ViajYta2JBV1kyakZkNTZfUjVFcko1T3poeXlLWU5OWkM1X2RuZDItT0JYZ25UME16TDU2bmtJV3UzSzREei1MTXdWWEdKaUdxVXN0SkRtRFBzOGdDZF9oUVhoSWs?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rainer Blair: Innovative Leader, Danaher Business System Champion, and President and Chief Executive Officer of Danaher Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxPY2NDWDNQdm1qOGVTcUljcnRpNWQ1bnk3TTVGREMxZ2RuaThXbl9hTEx2Vi1oV1BJVUtDNEtkc1dUNDFOZGROTDc5emFiNVFJSU1NdGU1RlBfV2cxUERGREJWSnlrWTF4ZVgwN29nS0dMN193bFdJUUZneFJnY05ENWlPTF9pbm1KSm14dDFUdWpHVTNiTW5DMWNFSThyR3ZTYjFhNXhCSGd1ODB0N3Z6YWRhTHBuZVRpdGpOblRzNzNnNEUySG5iMUtwRmwtOGhVMUxtQVBmd3hHZGQ5ZkRsZ1Y0WFZjc0ljNTJMZHFmNVVKWnc?oc=5", "source_name": "BBN Times", "published_at": "2026-05-06T22:51:07+00:00", "published_display": "06 May 2026 22:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher to webcast CEO remarks from May 13 Las Vegas conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPQ0E1dkt3R1hiOXdvNklwaXZuQm1wVDdqTjlNaVpVTnFnMkQ0Sk5HUHFpYTdwTUstaDhyd2J5NWdXbTdMbWlmQVNELXF3T2xieHpJSGU1a2dabC02NC1iVktwOUJOQU8yQmJIb2JQbng1WW41YjdPZk1qTzBrSUc2RjNPSy0zYXA3d0l3enlpYWY5Y0hmSXZUaURsSE1OR01STUZ0SnI4NEo5NG5Ib29tUzRUcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Margin Decline Challenges Bullish Earnings Growth Narrative In Q1 2026", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (NYSE: DHR) secures $5B 364-day revolving credit facility", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPcm5uWVBNNnhmZWM2Y3N2NEtsSUt3Z3lwUGZsTWsxd2NaaVRyNUstM2E1bmdFemYyY2U5eGhVM1NxSzFXME1UcWlURXQ3ZnhlQXJrWGg5bWkwN09lamw0bnNZUWp5MTJSR09JbjI2bkJscHdMVFpvYkg1OExWR3c3VmVoY2ZFdTNpSF9OWERKZjlwWXRlY25OdnZnSDZyc29wSFZwTDdn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Danaher Corporation (DHR) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPLV9WTkxpYUk0bS1kaFZ2YXpKNlNEd2pwczZSbEYxVUtGdVk2Zkh0REU3NXZwTThrQXZZRFI1NktHU2lGSkRwVWh4MVkxcUNRUTh1dVFXN0FTRzdoRHY2Q1E2eG9KT2tZWEtEaEdocUl0LThUcWZfeE5nVVlXNEppWnduazMxQVdERTc5cTk2a3ZCQ3pKMEZ1SEk1Z2FVMTU3?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US Premarket Movers: Danaher, Fiserv, General Mills, Masimo, Zim", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPQnRDektINE1BN3g5ZjA0aVo5bkNCVlNoeV83cjlFRzVCMGlGSVA5NC1pUmFpV1lCa0R5ZlF0bkFRQXdyT0MzWFFTSk1yTGpmTG9mbl8zQTZlSW1hQUhlWWJwUmlDaWtydmhSNkVWX0xzdTdCdjNFZ1dHX3cyNFU0aG1DY3lsbzktcjBXQ0FFUngyMlBrdUZBMXp5LVdkeDNjZkZSSmhVZS1sUktTYjNmT1EwRQ?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock fails to rise on solid earnings \u2014 leading us to question what's next", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQdXgxbWhEb2o0NlhBUTZZTUVIdkhuTEdwR1hMX0hZS0NkbXRPNHV3Tk9FYUVkOEJOd1BjdkpXbnhKdmM1bFF4c2tBT192MWgwb3VwUDExWHJFUXhRc0ZXVDJxZy1EcGxWZ09BWjVPU2I2QkM5Y19QaFpxOVBGTzVXdk03OGlXa0pkYXdqMjVmdjM3djVBOVBZeXJKZGdsZXA1SG1kNWl2UE9yRmZIMjV4VVBDS0hBTDQ?oc=5", "source_name": "CNBC", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Possible Bearish Signals With Danaher Insiders Disposing Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQdm1vRC1OY1JPNnI2ZUs2UGN1bTlMUmZfRnNoX0sxOTRVemMwSXBVUTNBaWotc2Rsb0NaQWtQSU8wemJ2X1RSVHhOZ0dRZXRrVWRLakg2b21OUGx1UjdfRjBVR2JEQ0hVSmxDd0ZVdTY3RjlmTGlPd3gzd1M2a0ZPY3NLdm4waDJHOVI5bmxGczI?oc=5", "source_name": "Market source", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS", "summary": "Danaher (DHR) is projected to report Q2 earnings of $1.84 per share and revenues of $6.09 billion, representing year-over-year increases of 2.2% and 2.6% respectively. Analysts have made slight downward adjustments to the EPS estimate, which can influence investor actions. Beyond", "url": "https://finance.yahoo.com/markets/stocks/articles/countdown-danaher-dhr-q2-earnings-131503448.html", "source_name": "Market source", "published_at": "2026-07-16T13:08:11", "published_display": "16 Jul 2026 13:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics", "summary": "Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform,", "url": "https://manufacturingchemist.com/leica-biosystems-acquires-statlab-to-strengthen-anatomic-pathology", "source_name": "Manufacturing Chemist", "published_at": "2026-07-16T11:26:45", "published_display": "16 Jul 2026 11:26", "sentiment": "positive", "sentiment_pct": 69, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (DHR) Price Events", "summary": "This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide trading strategies and multi-timeframe signal analysis. It indicates strong near and mid-term sentiment but a weak long-term outlook, highlighting a significant risk-reward short setup. The analysis ", "url": "https://news.stocktradersdaily.com/news_release/38/Liquidity_Mapping_Around_DHR_Price_Events_071626064402_1784198642.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-16T07:07:39", "published_display": "16 Jul 2026 07:07", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as diversified life sciences portfolio underpins long-term growth", "summary": "Danaher Corp. (ISIN US2358511028) is highlighted as a global life sciences and diagnostics supplier, appealing to long-term investors due to its diversified portfolio and recurring revenue streams. The company's focus on essential laboratory and clinical workflows, alongside stra", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-diversified-life-sciences-portfolio/69776007", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-16T00:42:00", "published_display": "16 Jul 2026 00:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher\u2019s Leica Biosystems to Acquire StatLab", "summary": "Danaher's Leica Biosystems is set to acquire StatLab, a privately-held manufacturer of anatomical pathology products. StatLab, with over 50 years of history, offers products for pre-analytical and analytical histology, complementing Leica Biosystems' focus on cancer diagnostics. ", "url": "https://www.mpo-mag.com/breaking-news/danahers-leica-biosystems-to-acquire-statlab/", "source_name": "Medical Product Outsourcing", "published_at": "2026-07-15T14:37:54", "published_display": "15 Jul 2026 14:37", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock may move 4.9% on July 21 earnings report By Investing.com", "summary": "Danaher Corp. (DHR) shares are expected to move 4.9% following its earnings report on July 21, based on options data. The stock has historically surpassed this options-implied movement in three of its last eight earnings announcements. Notably, on October 21, 2025, shares increas", "url": "https://za.investing.com/news/stock-market-news/danaher-stock-may-move-49-on-july-21-earnings-report-93CH-4368568", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T10:07:45", "published_display": "15 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Audax and Linden to sell StatLab Medical Products", "summary": "Audax Private Equity and Linden Capital Partners are reportedly selling StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation. The article, by Iris Dorbian, was published two hours prior to the provided crawl time. Further details about the dea", "url": "https://www.pehub.com/audax-and-linden-to-sell-statlab-medical-products/", "source_name": "PE Hub", "published_at": "2026-07-15T08:08:33", "published_display": "15 Jul 2026 08:08", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher's Leica Biosystems to Acquire StatLab Medical Products", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/danaher-apos-leica-biosystems-acquire-215836046.html", "source_name": "MT Newswires", "published_at": "2026-07-14T21:58:36+00:00", "published_display": "14 Jul 2026 21:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lab-products maker StatLab set to join Danaher\u2019s Leica", "summary": "Audax Private Equity and Linden Capital Partners have reached an agreement to sell StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation (NYSE: DHR). StatLab, a manufacturer of pre-analytical products for anatomic pathology, expanded globally a", "url": "https://www.stocktitan.net/news/DHR/audax-private-equity-and-linden-capital-partners-agree-to-sell-stat-cnl6do9mgva0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:24:38", "published_display": "14 Jul 2026 21:24", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Implied Volatility Surging for Danaher Stock Options", "summary": "Implied volatility for Danaher Corporation (DHR) stock options is surging, particularly for the Sept. 18, 2026 $140 Call, indicating that the market expects a significant price move. While analysts have slightly reduced current quarter earnings estimates, Danaher remains a Zacks ", "url": "https://www.tradingview.com/news/zacks:50863780b094b:0-implied-volatility-surging-for-danaher-stock-options/", "source_name": "TradingView", "published_at": "2026-07-14T20:07:38", "published_display": "14 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leica Biosystems to Acquire StatLab", "summary": "Leica Biosystems, a Danaher operating company and leader in precision cancer diagnostics, announced its definitive agreement to acquire StatLab Medical Products. StatLab, previously owned by Linden Capital Partners and Audax Private Equity, is a global developer and manufacturer ", "url": "https://finance.yahoo.com/healthcare/articles/leica-biosystems-acquire-statlab-203000239.html", "source_name": "Market source", "published_at": "2026-07-14T20:07:37", "published_display": "14 Jul 2026 20:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 DANAHER CORP /DE/ For: 14 July", "summary": "This article reports on a Form 144 filing for Danaher Corporation on July 14. It primarily consists of boilerplate disclaimers about the risks of trading in financial instruments and cryptocurrencies, emphasizing that the provided data may not be real-time or accurate. The conten", "url": "https://m.uk.investing.com/news/stock-market-news/form-144-danaher-corp-de-for-14-july-93CH-4770216?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-14T15:38:15", "published_display": "14 Jul 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] DANAHER CORP /DE/ SEC Filing", "summary": "This SEC filing, Form 144, for Danaher Corporation (DHR) concerns the proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing indicates a neutral impact and sentiment. It details the sale of 3298 shares of common stock, acquired via stock option exerc", "url": "https://www.stocktitan.net/sec-filings/DHR/144-danaher-corp-de-sec-filing-0fdb16e95ddd.html", "source_name": "Stock Titan", "published_at": "2026-07-14T15:16:03", "published_display": "14 Jul 2026 15:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMDFpdDB6ZVkxVWhJblZWR05wLUt3cV9wb2xzWTVfb3JaUXdCeUYzbjBXeHBFcU9uSGczWTNlSU9Vd21ueGFtT3N3WTRSQzRTWjZSb1UxMDdPVmJMa01fV3hDUXNvSXl4eTlxZ0RaTExuc0FNd1V2UVJaWGtSV052N2tucHJDM2FvVkFZWlhTWl8zQVB3ZGl1Q2RR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:00:09+00:00", "published_display": "14 Jul 2026 14:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as diversified diagnostics and life sciences portfolio supports long term", "summary": "Danaher stock reflects the company's diversified portfolio across diagnostics, biotechnology tools, and environmental solutions, which helps stabilize its performance for investors. The company's strategy involves acquiring niche businesses and integrating them into its science a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-diversified-diagnostics-and-life-sciences/69763195", "source_name": "Ad Hoc News", "published_at": "2026-07-14T02:26:46", "published_display": "14 Jul 2026 02:26", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-adjusts-price-target-danaher-135410367.html", "source_name": "MT Newswires", "published_at": "2026-07-13T13:54:10+00:00", "published_display": "13 Jul 2026 13:54", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as investors await the next catalyst", "summary": "Danaher stock is holding steady, focusing on its diagnostics, life sciences, and biotech tools franchises as investors look for new catalysts. The company, a major U.S. life-sciences and diagnostics name, benefits from diversification across its business mix, which includes tools", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-investors-await-the-next-catalyst/69758786", "source_name": "Ad Hoc News", "published_at": "2026-07-13T07:28:00", "published_display": "13 Jul 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as its life sciences platform stays central", "summary": "Danaher Corporation (DHR) maintains its stable market position due to its diversified life sciences, diagnostics, and biotechnology platform. The company's business model, heavily reliant on recurring revenue from instruments, consumables, and services, offers resilience compared", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-its-life-sciences-platform-stays-central/69749752", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T05:57:00", "published_display": "12 Jul 2026 05:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock holds steady as analysts frame the outlook", "summary": "Danaher Corporation's stock remains stable due to its extensive presence in the life sciences and diagnostics sectors, positioning it as a significant supplier across research, bioprocessing, and diagnostics markets. Its diversified business model, characterized by recurring dema", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-stock-holds-steady-as-analysts-frame-the-outlook/69741204", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:44:00", "published_display": "11 Jul 2026 06:44", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Is Getting Better, But The Stock Still Isn't Cheap (NYSE:DHR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNbUJQd2dnaUNhWFplV2RQd190Wnp0NTZNRDJBTEoza0tHcG1jNFlUN2tvM0JRXzFCSU1JLXFra2UzMXM1dmJZbjFkY21WaVhUZ1NvWU1FRHhBLWQzc1NLTGYxcmk2TW5Pc0IweUZ4RER2OHZ0dXNna3hpNmN0Z09tWTRkWXBhTGJqQXBfQy1fOXgwS2lpR0tCbUxLUm15dw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T21:44:45+00:00", "published_display": "10 Jul 2026 21:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Labs Vs. Danaher: Abbott\u2019s Everyday Products Beat Danaher\u2019s Slumping Biotech Equipment", "summary": "The article compares Abbott Laboratories (ABT) and Danaher (DHR) after their Q1 2026 earnings, highlighting Abbott's reliance on consumer medical devices like FreeStyle Libre and Danaher's dependence on bioprocessing tools. Abbott's consumer-facing products demonstrate recession-", "url": "https://247wallst.com/investing/2026/07/10/abbott-labs-vs-danaher-abbotts-everyday-products-beat-danahers-slumping-biotech-equipment/", "source_name": "24/7 Wall St.", "published_at": "2026-07-10T18:18:58", "published_display": "10 Jul 2026 18:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. stock outperforms competitors on strong trading day", "summary": "Danaher Corp. (DHR) stock rose 1.57% to $199.05 on Friday, outperforming the broader market indexes. The S&P 500 Index increased by 0.42%, and the Dow Jones Industrial Average gained 0.29%. This marked the second consecutive day of gains for Danaher's stock.", "url": "https://www.marketwatch.com/data-news/danaher-corp-stock-outperforms-competitors-on-strong-trading-day-1e1b34e2-1c759d009ffc", "source_name": "MarketWatch", "published_at": "2026-07-10T16:36:00", "published_display": "10 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Wins CE Mark For Access P Tau217 Assay, Is The Stock A Bargain?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNN2c1S0JjdkIxdWtVU2lzNWtnQXIybnV1OFViNXhhd0p1XzNkQmNNaDlnbFlkNEIyMUFCY3RrUHlWSzBxTXhaTnlsX1ZrbVNaZm5GcjVwaUl3N09aRGZ4cDUtc0VTVGpKZU1fSkVmQWxNQ3V0YzBhUy1VRGFkTFc5ZFlSZXNibjhzdG1TMDNtVnRtR2c?oc=5", "source_name": "Market source", "published_at": "2026-07-09T21:15:54+00:00", "published_display": "09 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Gains Attention On FDA Clearance, Is The Stock Fully Priced?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. focuses on life sciences growth as investors watch long-term strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOanZxV29EV1AyMHRaaFUzdFdndmg4dENqVGlHaENzR25NZDZSTkE3bEVNS2pxQ0pyVVdMN3B4ZGNmUE9vcWMzX1NndlYwVlhra3R4SGY3TmZlakVmVGZIcUpDTVhLdXRxc1NLSGZFY1kyWU9ZdkMwdE9IQ1BramdGTVlRekRrbHE1UmxDbE5BWmZIV09fdFhwa25KeHNXZUtPSlBzbFBDUXRLRU83Q3lpVU1PenJia1VpRHg3QTF6dy0wdTA1Y1hldW9yTjg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Weighs DCF Upside Against Premium P/E After Recent Bounce", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T19:27:10+00:00", "published_display": "30 Jun 2026 19:27", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQWlExWHROd2ItQUNCRTlRd3piNnBKUEFaV0NGMU8zcF9QbXdWdzdXYkw4cTNjU0p2ODhra0VKZlI0aldrMjFBMjYzM0pyalI3LUFTbmk5QnNhek83R1pGLVhuLU9FR1BDX1NkQTBQVFhqZzZybXZVR3dYcEZLbV9uaTdWWjlFVHQ1Q1ZsRldnZno0Rkk?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (NYSE: DHR) Stock price Drops 22% In 2026 As $9.9 Billion Masimo Deal Reshapes The Investment Case", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZl9ieDZYUlJzWmRxd3FfdGtqZzJqbHNoZWNGY3FYZ192Qzh2Y1UwTTFxNDJNNTFLcW51dXBrcGZDS2wtZi1tV1JFVXB6MWxCWGo1VG5fQW9lbUtzUHQ2SlFJVlRwcGdCV1JDVzZ2QkpaMV84NlRSeGdrbzJyeVFYUUxMdk52OE9ZTWJJVWlGdl93UEhSNFFadjRtV3NYSklNT0xyN2twaEw4SW1aYjZpcWZJU3U4cWluM2ZVdTJaVWVuN2dfcGxsV1FEM0FPTzBtRjlUck1wMm5wYUUzYlpfRnE3eHg?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-25T13:32:00+00:00", "published_display": "25 Jun 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Is Up, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNW1IS19mZjk2Z1hIajlLbjhCWjJlV3JtX29CaE1IazV6S1lOVlNFUWhNNWNKZXYzTHVMdXJmMC10V3FrQzlEd2g2dkh6VF9tZkhlMmNCN0JQelZlZ1MwMkpTbFdqUHJudERGOG5VWjBjd2NGRzJjVF9jRDZCazMtSmJ5NHZCZ2V1ZzQtWExpbDM?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Danaher (DHR) Stock Rose Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBZV24yRXVIZVpwOF9CN3BuNXVUa2JVOU1tazQxRDAzUV83TXVPVkk5TzRVcUEzb3BzaFpobnA0elQ2cTd6R0M2alphV09lM2pRdVVjY3JZd2FWUm5pOGJKYzE0ZzdZZ2dNSTAySTJ5TGNqZjRiMTRUUUY1TQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOVXpJeHNKTlYzQTR6Wkg4dFdWbTRydFFKWlBfOE1YV0lOdnlqVF9LWll0Smw3S1NLbHRBTzNDOUJaSzhCQ2txVW9qRTY3OFZvRzh0V0tDU25BekNuMGJFS2h3Z1MxMWpHb3NocTJaUVlQS1NqUXZwN3pJNGs0d3diR2VYVVVCZnUzX0VIQ0tXXzQ5ZWtaUVMyV2hiWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher\u2019s (DHR) Clinical Data Advantage", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HSBC Cuts PT on Danaher Corporation (DHR) \u2013 Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNWXRQYWJ1NDgtNm0yV2YwcHJQLUFrTWo5U015aXBEeVRYSy1BWXl0RXdKbk85Uy1sQmdHcGlSRWcxNUFfRGFqbFpES3Zvdk9XUHhpQW1oSjE5V0UzcXZBbThrUXBrbzUtcEQzdkFBOUp6clBfczg5Uk1sUGlncWNYQzVXNS12S2gyNC16UmxoUUh5S1dYRjVzUjg0aWZkUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why You Might Be Interested In Danaher Corporation (NYSE:DHR) For Its Upcoming Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corporation\u2019s (DHR) Recovery Fell Short of Investor Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNaGt6RWlsOVQ3T2xGSGxYT3VpRkJVXzlneGgwRUxONWtTSmxkNnJteVZ3U29UYkFwMmVQclFraDE0VDRCc25oZFFhVlVZYjN6ekxad05OZUgtS29yNmR4N2pGeU82Z0FUVEZQZmpkb09DZHRUdWdiUVZJc2xyR1dtcDMyTDktNGw3SFdRZGNTUU1CRnZHMlFMTm5GTU92bHlGV2ZabA?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaEhzdTJLeWZnYkl2U2lmcFVTN0VldGxyLUZ3UEFTZkl2Z3ZZQkxfOXlqTmpfdFBJRHU0X0lhb2VpeEFYMG5TdmU3T1VNUHdBaEZ1bEVkSDYweW5uNXJiMndOd3NiUG9raXo3cHJrXzhoUGJnSWYtUmNJZGJYeGRfc0pRVlVFOXdDTld1MEN0UEVOVi12Q2wzODZ4a1pHRzFGcTZiMEFrLTdaUjBVOEJZTW9ZOGkxS0Z6OVhGaHNDUjYzelpT0gHKAUFVX3lxTE0xVkQ3QVBkeHBXLWRtVkktRW14ak05THV4aW13ZW9Yck5TUm1tNlFFaW02NGt2LXFjNE45OWd2dUdVd2xHR0UxRVBUclM0clFFNEtmMDZNVWpBYTN4UXpqVUkzUlo2blZTaUY1U3BhQ1MtSjNxRlRkQ1NVU0lld2xkMk9BSHd3VnZsbXVXZFIxY2pEamhSeXB6WFN4eG5mU3FXd2FtMkoyNkZNTTMxdU03ZHV6TVMwalRxcnI1Qmt2NDhZYzJfc1JLRXc?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Completes Acquisition of Masimo Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPWXdTanBwOEJMaXFoTU4xZl9FQ28yNk1YSVRsQVZYei1weW5ZUFNHQk9RTlQ2MUNWZVViR2FDVEwwQ29wTUh1VzljQVY3VW51aEx6bms0MEtoV1V0bEg1cS05SFFrQUtLc0tGMGxETEVHejBoczh0X2JFUGlvZTNkUXExdkRMVF9MdjFWSDZ4RE54NTJZdzR1RXN5WDc3Z2ZsSkRYS0t2ZlRVWXVrdzl4RC1RTQ?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQYUdlR2xKUHRlajdLeWVPMEFKbUxvalQ4NXZqU2lONDJZenM1UjV3TFFjWTQycTlkNHZ5cHVWWWlpQVc0YnVFMzNwTDdrclRiRWFIWlZSQWlubk5VTjZxZ0d3UHh5MkdYVThsSDVnZjdDWnVwMlpOQ0JfMko3Q0VqdEx2NVN3ZjNnVFZkMnQtTmp4cWRzRm14TTRkQUhjUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZk5FdWNPWnVUWWR0dnpWM0NUNUZkLXphcUZjYjdGX1daNDRqM3daQkdablpqSVZSMldqNExjYlhRQlBETlgwS1c5b0xLOUE2bDFkdm8wOTBrVnphc1FiWUlYNWpEMXg1cUZuY3ZHOHUwbDFjV2Zadl85Q3ZPd0lOQlFxekxQLTV2bExpVGNjY1FENXNwYS1xbzNIYTUyd2FaOXNyVEtQODQ5WWNEQk9mbTRXR24xT2ZOdWNJTWZnRFRrVmJ1Unc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock (US2358511028): Shares slide as institutional holdings shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNTjFMRGNHYXBGdEZQY3JRVTFHcUdDbUJMX01WVUthdmtfNjJ0UElFSW1pVlJjR1M4MHdTWExyR0dQSWZjRFJ5aERjRmRCb2VpQjJmaXlhS210TFozSEtNM2dDbFAzVlI3Nm5lWkdrVEtwdzJzd0RueTRuZ09FSEZQYThaLWFkeGNMelpYajJnWHAwQTdndHJwY2dBWjgwaW9hOTJGbzBVTUZZYVJSdDdJZEZyckd0NUQ3NzFqUTE2YkZ4T21MVWc4VFRR?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Corp. Stock (US2358511028): Analyst Downgrades and 52-Week Low Test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPeTllekpBbXZaZzBLc21HQXBwOFRldGtBNDBmQkktTUxXcXJQWndCSnI0S2tQdzY3UkxfRDB5M0EyTWxTQjFSLWo0REU4QTMxMFNFZGp6bTlhcXFPQnRfbUhWTkNzT0ViajYta2JBV1kyakZkNTZfUjVFcko1T3poeXlLWU5OWkM1X2RuZDItT0JYZ25UME16TDU2bmtJV3UzSzREei1MTXdWWEdKaUdxVXN0SkRtRFBzOGdDZF9oUVhoSWs?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rainer Blair: Innovative Leader, Danaher Business System Champion, and President and Chief Executive Officer of Danaher Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxPY2NDWDNQdm1qOGVTcUljcnRpNWQ1bnk3TTVGREMxZ2RuaThXbl9hTEx2Vi1oV1BJVUtDNEtkc1dUNDFOZGROTDc5emFiNVFJSU1NdGU1RlBfV2cxUERGREJWSnlrWTF4ZVgwN29nS0dMN193bFdJUUZneFJnY05ENWlPTF9pbm1KSm14dDFUdWpHVTNiTW5DMWNFSThyR3ZTYjFhNXhCSGd1ODB0N3Z6YWRhTHBuZVRpdGpOblRzNzNnNEUySG5iMUtwRmwtOGhVMUxtQVBmd3hHZGQ5ZkRsZ1Y0WFZjc0ljNTJMZHFmNVVKWnc?oc=5", "source_name": "BBN Times", "published_at": "2026-05-06T22:51:07+00:00", "published_display": "06 May 2026 22:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher to webcast CEO remarks from May 13 Las Vegas conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPQ0E1dkt3R1hiOXdvNklwaXZuQm1wVDdqTjlNaVpVTnFnMkQ0Sk5HUHFpYTdwTUstaDhyd2J5NWdXbTdMbWlmQVNELXF3T2xieHpJSGU1a2dabC02NC1iVktwOUJOQU8yQmJIb2JQbng1WW41YjdPZk1qTzBrSUc2RjNPSy0zYXA3d0l3enlpYWY5Y0hmSXZUaURsSE1OR01STUZ0SnI4NEo5NG5Ib29tUzRUcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Margin Decline Challenges Bullish Earnings Growth Narrative In Q1 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNWjNPT3BONmh3SVJQRlBGdkVZYlpvcWg3blNfX2s1SnR1T19idjlEOUNDV2tEY29Bb1lHcERtOGRYRl9kVWV6UlZwWEJsVDI1XzEwV1I1eHBteXh0NmJycG5penpweUZUbnVQQmxYRVRlWVRLMnhrXzBydEFTTG16ZEZVdjZ3dHR4NGpSVlZkSW1wVWJSLUxQaFU3TDJrT05JZVh0TjZuNHBpRzJNRW9HU3Qxcjdad1dyMkN3NjlnblhOS1JCZFhzbmNULThYWVI5UWJ1edIB2gFBVV95cUxPNFY0eXkta2trVGppWF9fYkRDMS0wOW8zMHlKYkY2OS1FdVF4WlV6d1BXTmJ5ZUpESFRienQ3WGJ0eExGbVpJNjA0X3dQdGdOTlVhVVZDaTY1V3dRa24yVFpwQVZYakh4ejgyOVNaTXdPTFlOaWF0bXBEMXp5anBTTzllUloxM2dMdHZab2FLeUM4OHJNc0MzVy01NGhaa3NOVGVpX3g3dUY3RnE0TlZYU2pnSF82LXpxN3lBcElXQkhNanljazQ0aDdDVjUwSFAxbjgtUnRmZmJpdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (NYSE: DHR) secures $5B 364-day revolving credit facility", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPcm5uWVBNNnhmZWM2Y3N2NEtsSUt3Z3lwUGZsTWsxd2NaaVRyNUstM2E1bmdFemYyY2U5eGhVM1NxSzFXME1UcWlURXQ3ZnhlQXJrWGg5bWkwN09lamw0bnNZUWp5MTJSR09JbjI2bkJscHdMVFpvYkg1OExWR3c3VmVoY2ZFdTNpSF9OWERKZjlwWXRlY25OdnZnSDZyc29wSFZwTDdn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Danaher Corporation (DHR) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPLV9WTkxpYUk0bS1kaFZ2YXpKNlNEd2pwczZSbEYxVUtGdVk2Zkh0REU3NXZwTThrQXZZRFI1NktHU2lGSkRwVWh4MVkxcUNRUTh1dVFXN0FTRzdoRHY2Q1E2eG9KT2tZWEtEaEdocUl0LThUcWZfeE5nVVlXNEppWnduazMxQVdERTc5cTk2a3ZCQ3pKMEZ1SEk1Z2FVMTU3?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US Premarket Movers: Danaher, Fiserv, General Mills, Masimo, Zim", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPQnRDektINE1BN3g5ZjA0aVo5bkNCVlNoeV83cjlFRzVCMGlGSVA5NC1pUmFpV1lCa0R5ZlF0bkFRQXdyT0MzWFFTSk1yTGpmTG9mbl8zQTZlSW1hQUhlWWJwUmlDaWtydmhSNkVWX0xzdTdCdjNFZ1dHX3cyNFU0aG1DY3lsbzktcjBXQ0FFUngyMlBrdUZBMXp5LVdkeDNjZkZSSmhVZS1sUktTYjNmT1EwRQ?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher stock fails to rise on solid earnings \u2014 leading us to question what's next", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQdXgxbWhEb2o0NlhBUTZZTUVIdkhuTEdwR1hMX0hZS0NkbXRPNHV3Tk9FYUVkOEJOd1BjdkpXbnhKdmM1bFF4c2tBT192MWgwb3VwUDExWHJFUXhRc0ZXVDJxZy1EcGxWZ09BWjVPU2I2QkM5Y19QaFpxOVBGTzVXdk03OGlXa0pkYXdqMjVmdjM3djVBOVBZeXJKZGdsZXA1SG1kNWl2UE9yRmZIMjV4VVBDS0hBTDQ?oc=5", "source_name": "CNBC", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Possible Bearish Signals With Danaher Insiders Disposing Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQdm1vRC1OY1JPNnI2ZUs2UGN1bTlMUmZfRnNoX0sxOTRVemMwSXBVUTNBaWotc2Rsb0NaQWtQSU8wemJ2X1RSVHhOZ0dRZXRrVWRLakg2b21OUGx1UjdfRjBVR2JEQ0hVSmxDd0ZVdTY3RjlmTGlPd3gzd1M2a0ZPY3NLdm4waDJHOVI5bmxGczI?oc=5", "source_name": "Market source", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 104, "total_relevant": 51, "sentiment_summary": {"positive": 22, "negative": 3, "neutral": 26, "score": 58, "total": 51, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 18.1, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 5.85, "count": 10}, {"event": "deals", "label": "Deals and strategy", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 22, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 199.05, "latest_week": "2026-07-10", "one_week_move": 0.6, "four_week_move": 10.7, "twelve_week_move": 2.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.530789, "market_dynamics_buy_signal": false, "relative_strength": -11.6461, "fair_value_gap": -9.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.5887, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.6% over one week, +10.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Ad Hoc News", "count": 7}, {"label": "simplywall.st", "count": 6}, {"label": "Stock Titan", "count": 4}, {"label": "MT Newswires", "count": 2}, {"label": "ad-hoc-news.de", "count": 2}, {"label": "Manufacturing Chemist", "count": 1}, {"label": "Stock Traders Daily", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 51}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 10}, {"label": "Deals and strategy", "count": 4}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "51", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.6% over one week, +10.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS"}], "updated_at": "2026-07-16T17:00:57.997153+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}